Medicare Enrolled
Dr. Michael Metzger, M.D.
Cardiovascular Disease · Delray Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Metzger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Metzger? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Metzger
Dr. Michael Metzger is a cardiovascular disease in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Metzger performed 14,283 Medicare services across 6,902 unique beneficiaries.
Between the years covered by Open Payments, Dr. Metzger received a total of $53,706 from 65 pharmaceutical and/or device companies across 1002 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Metzger is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in FL$ $53,706 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,283
Medicare services
Top 3% in FL for cardiovascular disease
6,902
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~752 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 2,651 | $73 | $118 |
| Electrocardiogram (EKG), 12-lead | 1,215 | $12 | $27 |
| Remote patient monitoring management, 20 min/month | 1,156 | $40 | $80 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,085 | $30 | $55 |
| Office visit, established patient (30-39 min) | 1,028 | $105 | $170 |
| Remote patient monitoring device, 30 days | 836 | $40 | $95 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 701 | $22 | $44 |
| EKG interpretation and report | 637 | $7 | $9 |
| Hospital follow-up visit, high complexity | 559 | $99 | $164 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 506 | $32 | $66 |
| Remote pacemaker/defibrillator monitoring, 90 days | 422 | $18 | $40 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 390 | $21 | $44 |
| Echocardiogram, transthoracic | 327 | $159 | $321 |
| New patient office visit (45-59 min) | 327 | $136 | $260 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 306 | $90 | $177 |
| Remote pacemaker monitoring, 90 days | 299 | $24 | $50 |
| Initial hospital admission, high complexity | 289 | $144 | $320 |
| Injection, dipyridamole, per 10 mg | 200 | $3 | $48 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 161 | $51 | $110 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 153 | $357 | $736 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 129 | $29 | $61 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 99 | $154 | $303 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 76 | $21 | $43 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 76 | $668 | $1,083 |
| Ultrasound of heart with probe in esophagus, with report | 68 | $86 | $172 |
| Ultrasound of heart blood flow, valves and chambers | 68 | $14 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $2 | $5 |
| Cardiac catheterization | 59 | $216 | $507 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 50 | $98 | $189 |
| Prothrombin time test (blood clotting) | 48 | $4 | $12 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 45 | $1,380 | $2,969 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 43 | $18 | $36 |
| Insertion of heart rhythm monitor under skin | 37 | $3,541 | $7,799 |
| Injection of chemical agent into multiple incompetent veins of leg | 29 | $206 | $316 |
| Ultrasonic guidance for needle placement | 29 | $48 | $89 |
| Ultrasound of both sides of head and neck blood flow | 29 | $148 | $310 |
| Coronary stent placement | 23 | $485 | $1,031 |
| Programming of dual lead pacemaker system | 19 | $65 | $112 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 15 | $16 | $29 |
| External shock to heart to regulate heart beat | 13 | $90 | $250 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $296 | $643 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.9% high complexity
5.8% medium
84.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$53,706
Total received (2018-2024)
Avg $7,672/year across 7 years
Top 8% in FL for cardiovascular disease
65
Companies
1,002
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,602 (42.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,607 (32.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,497 (25.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,967
2023$12,843
2022$10,339
2021$9,225
2020$2,594
2019$11,658
2018$3,080
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$17,844
Inari Medical, Inc.
$13,943
Abbott Laboratories
$2,935
Penumbra, Inc.
$2,421
Janssen Pharmaceuticals, Inc
$1,352
Amgen Inc.
$1,349
AstraZeneca Pharmaceuticals LP
$1,100
Philips Electronics North America Corporation
$1,096
ShockWave Medical, Inc
$973
PFIZER INC.
$787
Novartis Pharmaceuticals Corporation
$719
Amarin Pharma Inc.
$708
ABIOMED
$671
SANOFI-AVENTIS U.S. LLC
$662
Boehringer Ingelheim Pharmaceuticals, Inc.
$639
E.R. Squibb & Sons, L.L.C.
$622
Actelion Pharmaceuticals US, Inc.
$547
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$344
Kowa Pharmaceuticals America, Inc.
$334
Lundbeck LLC
$322
CVRx, Inc.
$321
Merck Sharp & Dohme LLC
$312
HeartFlow, Inc.
$296
Impulse Dynamics (USA) Inc.
$292
Bard Peripheral Vascular, Inc.
$274
Medtronic, Inc.
$273
Cook Medical LLC
$233
Medtronic Vascular, Inc.
$223
Edwards Lifesciences Corporation
$182
Regeneron Healthcare Solutions, Inc.
$158
Kestra Medical Technology Services, Inc.
$153
Gilead Sciences, Inc.
$133
Novo Nordisk Inc
$129
Bolton Medical Inc
$99
Chiesi USA, Inc.
$98
Alnylam Pharmaceuticals Inc.
$80
Esperion Therapeutics, Inc.
$76
CARDIVA MEDICAL, INC.
$71
Bayer HealthCare Pharmaceuticals Inc.
$66
Braemar Manufacturing, LLC
$65
Kiniksa Pharmaceuticals, Ltd.
$60
Becton, Dickinson and Company
$60
Kiniksa Pharmaceuticals International, plc
$60
Lexicon Pharmaceuticals, Inc.
$58
Tactile Systems Technology Inc
$52
United Therapeutics Corporation
$51
Merck Sharp & Dohme Corporation
$44
GE HEALTHCARE
$44
BIOTRONIK INC.
$43
Bayer Healthcare Pharmaceuticals Inc.
$39
BOSTON SCIENTIFIC CORPORATION
$38
Shockwave Medical, Inc
$27
Vital Connect, Inc
$24
ACIST MEDICAL SYSTEMS, INC.
$22
ZOLL Circulation Inc
$22
Akcea Therapeutics, Inc.
$20
CSL Behring
$19
ARBOR PHARMACEUTICALS, INC.
$18
Astellas Pharma US Inc
$16
Cardinal Health 200, LLC
$16
Biocompatibles, Inc.
$16
CORDIS US CORP.
$16
G Medical Diagnostic Services, Inc.
$14
CHIESI USA, INC.
$13
ARALEZ PHARMACEUTICALS US INC.
$13
Top 3 companies account for 64.7% of total payments
Associated products mentioned in payments ›
(6554) Periph Vasc Undiv · (6582) Visions 035 · AMPLATZER AMULET · AVEIR · Arcalyst · Assure WCD · Assurity Pacemaker · BELSOMRA · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · CLEVIPREX · CONFIRM RX · CT THROMBECTOMY SYSTEM KIT · CVI SYSTEMS · Cardiac Monitoring Suite · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · CareLink · ClosureFast · Cobalt · Confirm Rx · Corlanor · ELIQUIS · ENSITE · ENTRESTO · Edarbi · EnSite Precision Cardiac Mapping System · EnSite X · Ensite Cardiac Mapping System · Evera · FARXIGA · FFRct · FLOWTRIEVER CATHETER · Flexitouch Plus · FlowTriever · General - Therapies · IGT D Peripheral · INVOKANA · Impella · Indigo System · JARDIANCE · KENGREAL · Kcentra · Kerendia · LEQVIO · LEXISCAN · LIVALO · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · MYNXGRIP · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Optimizer · Optimizer Smart System · Ozempic · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · PressureWire FFR · Quadra Assura CRT Defibrillator · RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM · RUBY Coil · Repatha · Reveal LINQ · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEGSEDI · TYVASO · TherOx DS2 Console · Tryton Side Branch Stent · UPTRAVI · VARITHENA · VERQUVO · VITALPATCH RTM · VYNDAMAX · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaSeal · Venclose Maven Catheter · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xience Sierra Coronary Stent System · ZONTIVITY · Zilver Vena
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (42%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for cardiovascular disease in FL.
Equivalent to $376 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
226
Per 100K population
15.0
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Metzger is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (mixed engagement, top 8%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Metzger experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Metzger performed 2,651 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Metzger receive payments from pharmaceutical companies?
Yes. Dr. Metzger received a total of $53,706 from 65 companies across 1,002 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Metzger's costs compare to other cardiovascular diseases in Delray Beach?
Dr. Metzger's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Metzger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Delray Beach
Browse cardiovascular diseases in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Inari Medical, Inc. Payments to Doctors
See all physicians who received payments from Inari Medical, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology